scholarly article | Q13442814 |
P356 | DOI | 10.1592/PHCO.31.11.1045 |
P698 | PubMed publication ID | 22026392 |
P2093 | author name string | Mohsen Rezaei Hemami | |
Mania Radfar | |||
Toktam Faghihi | |||
Amir Hoshang Ehsani | |||
Zohre Mehrabian | |||
P2860 | cites work | Psoriasis: targeting therapy towards the inflammatory cascade | Q37768402 |
Psoriasis and cardiovascular diseases | Q37776250 | ||
Psoriasis: from pathogenesis to novel therapeutic approaches | Q37789387 | ||
Inflammatory markers, cholesterol and statins: pathophysiological role and clinical importance. | Q37792117 | ||
Statins in dermatology. | Q37801956 | ||
Simvastatin in psoriasis: ambiguous effects | Q43007088 | ||
Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: Comparison of adverse event–free response days in the CHAMPION trial | Q45129897 | ||
Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? | Q53517010 | ||
Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis | Q28270369 | ||
Intensive versus moderate lipid lowering with statins after acute coronary syndromes | Q29619716 | ||
Clinical improvement in psoriasis with treatment of associated hyperlipidemia | Q34158912 | ||
Anti-inflammatory and immunomodulatory effects of statins. | Q34163404 | ||
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial | Q34550538 | ||
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION). | Q34585521 | ||
Psoriasis assessment tools in clinical trials | Q35579443 | ||
Statins: novel additions to the dermatologic arsenal? | Q35798211 | ||
Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiences | Q35843827 | ||
Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review | Q36879686 | ||
Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach | Q37242931 | ||
Immunomodulation by statins: mechanisms and potential impact on autoimmune diseases | Q37541814 | ||
Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. | Q37742713 | ||
Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions | Q37743164 | ||
Do structural differences in statins correlate with clinical efficacy? | Q37768005 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1045-1050 | |
P577 | publication date | 2011-11-01 | |
P1433 | published in | Pharmacotherapy | Q7180800 |
P1476 | title | Atorvastatin for the treatment of plaque-type psoriasis. | |
P478 | volume | 31 |
Q41038631 | Adherence to statins and the risk of psoriasis: a population-based cohort study |
Q50333986 | Atorvastatin as an adjuvant with betamethasone valerate reduces disease severity and cardiovascular risks in Psoriasis |
Q64080894 | Comparison of efficacy and safety of atorvastatin 5% lotion and betamethasone 0.1% lotion in the treatment of scalp seborrheic dermatitis |
Q38749538 | Effectiveness of Lipid-Lowering Statin Therapy in Patients With and Without Psoriasis |
Q64946734 | Linking CD1-Restricted T Cells With Autoimmunity and Dyslipidemia: Lipid Levels Matter. |
Q28535430 | Novel factors in the pathogenesis of psoriasis and potential drug candidates are found with systems biology approach |
Q38113531 | Rational for statin use in psoriatic patients. |
Q42555894 | Statin use and osteoarthritis |
Q38056160 | The association between psoriasis and dyslipidaemia: a systematic review |
Q89687364 | The effect of statins on psoriasis severity: a meta-analysis of randomized clinical trials |
Search more.